Funding was led by B Capital group, and existing investors participated in the round, according to a news release. Widya Mulyasasmita, PhD, a senior investor at B Capital Group, will join Carlsmed’s board as an observer.
Carlsmed’s Aprevo implants are patient-specific and designed for spinal fusions. The device was granted two CMS payments in 2021.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
